Advertisement
Canada markets closed
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7322
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    83.45
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    91,143.93
    -388.98 (-0.42%)
     
  • CMC Crypto 200

    1,433.05
    +18.29 (+1.29%)
     
  • GOLD FUTURES

    2,335.30
    -6.80 (-0.29%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0520 (-1.12%)
     
  • NASDAQ futures

    17,711.25
    +104.50 (+0.59%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    38,260.77
    +708.61 (+1.89%)
     
  • CAD/EUR

    0.6833
    -0.0003 (-0.04%)
     

Is Now The Time To Look At Buying Hamilton Thorne Ltd. (CVE:HTL)?

Hamilton Thorne Ltd. (CVE:HTL), which is in the medical equipment business, and is based in United States, led the TSXV gainers with a relatively large price hike in the past couple of weeks. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, what if the stock is still a bargain? Let’s take a look at Hamilton Thorne’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for Hamilton Thorne

Is Hamilton Thorne still cheap?

Good news, investors! Hamilton Thorne is still a bargain right now. My valuation model shows that the intrinsic value for the stock is CA$2.28, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. What’s more interesting is that, Hamilton Thorne’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What does the future of Hamilton Thorne look like?

TSXV:HTL Past and Future Earnings, February 24th 2020
TSXV:HTL Past and Future Earnings, February 24th 2020

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. In the upcoming year, Hamilton Thorne’s earnings are expected to increase by 62%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? Since HTL is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on HTL for a while, now might be the time to enter the stock. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy HTL. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Hamilton Thorne. You can find everything you need to know about Hamilton Thorne in the latest infographic research report. If you are no longer interested in Hamilton Thorne, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.